BSGM icon

BioSig Technologies, Inc. Common Stock

5.37 USD
+0.07
1.32%
Updated Aug 26, 9:37 AM EDT
1 day
1.32%
5 days
10.04%
1 month
17.51%
3 months
-16.22%
6 months
388.18%
Year to date
283.57%
1 year
437.00%
5 years
-93.01%
10 years
-91.95%
 

About: BioSig Technologies Inc is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. The PURE EP Platform enables electrophysiologists to acquire raw signal data in real-time, absent unnecessary noise or interference, to maximize procedural success and minimize unnecessary inefficiencies.

Employees: 5

0
Funds holding %
of 7,429 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

2,335% more capital invested

Capital invested by funds: $4.69M [Q1] → $114M (+$109M) [Q2]

100% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

25.77% more ownership

Funds ownership: 32.79% [Q1] → 58.56% (+25.77%) [Q2]

18% more funds holding

Funds holding: 28 [Q1] → 33 (+5) [Q2]

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$10
86%
upside
Avg. target
$10
86%
upside
High target
$10
86%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Ascendiant Capital
Edward Woo
86%upside
$10
Buy
Maintained
6 Jun 2025

Financial journalist opinion

Based on 4 articles about BSGM published over the past 30 days

Neutral
GlobeNewsWire
1 week ago
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
Offering Structured to Accelerate Streamex's Operational Build-Out, Strategically Allocated with No Warrants Offering Structured to Accelerate Streamex's Operational Build-Out, Strategically Allocated with No Warrants
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
Neutral
GlobeNewsWire
1 week ago
BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), today announced the pricing of its previously announced underwritten public offering of 3,852,149 shares of common stock at a public offering price of $3.90 per share. The offering is expected to close on or around August 15, 2025 subject to customary closing conditions. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses are expected to be approximately $15,023,381.10. BioSig intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.
BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
Neutral
GlobeNewsWire
1 week ago
BioSig Technologies Inc. Announces Proposed Public Offering
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”) which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM) today announced its intention to offer shares of common stock (or pre-funded warrants in lieu thereof) through an underwritten public offering. All of the shares of common stock (or pre-funded warrants in lieu thereof) are being offered by the Company. The completion of the offering remains subject to market conditions, with no assurance regarding its timing, size, or terms. The Company intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.
BioSig Technologies Inc. Announces Proposed Public Offering
Neutral
Business Wire
2 weeks ago
BIOSIG TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of BioSig Technologies, Inc. - BSGM
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of BioSig Technologies, Inc. (NasdaqCM: BSGM) and Streamex Exchange Corporation. Upon closing of the proposed transaction, current BioSig shareholders and holders of common stock equivalents will hold 25% of the fully diluted BioSig common stock outstanding. KSF is seeking to determine whether the me.
BIOSIG TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of BioSig Technologies, Inc. - BSGM
Neutral
Business Wire
1 month ago
CORRECTION: BioSig & Streamex Clarify and Correct Details of Russell Starr's Appointment and Biography
VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)--BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM), issues a correction to the press release regarding the appointment of Russell Starr as Strategic Advisor to Streamex, published on July 11, 2025. The correction concerns a clarification in the press release with respect to stated aspects of Mr. Starr's biography, including his most recent role and.
CORRECTION: BioSig & Streamex Clarify and Correct Details of Russell Starr's Appointment and Biography
Neutral
Business Wire
1 month ago
BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations
LOS ANGELES & VANCOUVER, British Columbia--(BUSINESS WIRE)--BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig”), which recently merged with Streamex Exchange Corporation (“Streamex”) (together, “BSGM” or the “Company”), is excited to announce a critical step toward becoming one of the first fully regulated Real-World Asset (“RWA”) tokenization companies trading on a major United States exchange: Streamex has engaged Compliance Exchange Group (CXG) to lead and manage the acquisition of a specifi.
BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations
Neutral
Business Wire
1 month ago
CORRECTING and REPLACING BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor
VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)--Please replace the release dated July 11, 2025 with the following corrected version due to revisions to details of Russell Starr's appointment and biography. During this period, Mr. Starr was not the Chief Executive Officer of the Company, but instead served as Head of Capital Markets Consultant at DeFi Technologies. The updated release reads: BIOSIG & STREAMEX APPOINT DEFI EXPERT AND VISIONARY, RUSSELL STARR AS STRATEGIC ADVISOR B.
CORRECTING and REPLACING BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor
Neutral
Business Wire
1 month ago
BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor
VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)--BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM), is pleased to announce the appointment of Russell Starr as Strategic Advisor to Streamex. Mr. Starr brings decades of experience in capital markets, business development, and transformative deal-making across, defi, traditional finance and emerging sectors. A former executive on Bay Street and res.
BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor
Neutral
GlobeNewsWire
2 months ago
BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors
Los Angeles, CA & Vancouver, BC, June 09, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig”), which acquired Streamex Exchange Corporation as its wholly owned subsidiary (“Streamex”) in May 2025, is pleased to announce the appointment of Trevor Bacon and Kellan Grenier, co-founders of Parcl, as Strategic Advisors. Together, they bring deep expertise at the intersection of decentralized finance, synthetic asset creation, and real-world asset tokenization.
BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors
Neutral
GlobeNewsWire
2 months ago
BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor
Los Angeles, CA and Vancouver, BC, June 04, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig”), which acquired Streamex Exchange Corporation as its wholly owned subsidiary (“Streamex”) in May 2025, is pleased to announce the appointment of Sean Roosen as Strategic Advisor to Streamex. Mr. Roosen, a globally recognized mining entrepreneur and financier, brings over three decades of experience in building and scaling multibillion-dollar resource ventures.
BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor
Charts implemented using Lightweight Charts™